Abstract

RNA technology has the potential to revolutionize vaccination. However, the lack of clear structure-property relationships in relevant biological models mean there is no clear consensus on the chemical motifs necessary to improve RNA delivery. In this work, we describe the synthesis of a series of copolymers based on the self-hydrolyzing charge-reversible polycation poly(dimethylaminoethyl acrylate) (pDMAEA), varying the lipophilicity of the additional co-monomers. All copolymers formed stable polyplexes, showing efficient complexation with model nucleic acids from nitrogen/phosphate (N/P) ratios of N/P = 5, with more hydrophobic complexes exhibiting slower charge reversal and disassembly compared to hydrophilic analogues. The more hydrophobic copolymers outperformed hydrophilic versions, homopolymer controls and the reference standard polymer (polyethylenimine), in transfection assays on 2D cell monolayers, albeit with significantly higher toxicities. Similarly, hydrophobic derivatives displayed up to a 4-fold higher efficacy in terms of the numbers of cells expressing green fluorescent protein (GFP+) cells in ex vivo human skin (10%) compared to free RNA (2%), attributed to transfection enrichment in epithelial cells. In contrast, in a mouse model, we observed the reverse trend in terms of RNA transfection, with no observable protein production in more hydrophobic analogues, whereas hydrophilic copolymers induced the highest transfection in vivo. Overall, our results suggest an important relationship between the vector lipophilicity and RNA transfection in vaccine settings, with polymer biocompatibility potentially a key parameter in effective in vivo protein production.

Highlights

  • The activity of RNA therapeutics relies on the efficient delivery of the nucleic acid to the cytosol of the cells at the target site, where it is translated into the active protein

  • We report here a systematic mechanistic study utilizing a library of poly(dimethylaminoethyl acrylate) (pDMAEA) copolymers, varying the co-monomer lipophilicity to study (a) the effect on hydrolysis rate, (b) if this effects the pH-independent mechanism, and (c) the implications of the co-monomer and charge reversal on mRNA delivery from the perspective of vaccination

  • We designed a systematic library of chargereversible polymeric gene delivery vectors, varying the relative lipophilicity of copolymers based on the self-catalyzed hydrolysis of pDMAEA

Read more

Summary

Introduction

Several mRNA therapies have undergone, or are currently undergoing clinical trials,[6−8] while their manufacturability is currently under investigation.[9,10]. The activity of RNA therapeutics relies on the efficient delivery of the nucleic acid to the cytosol of the cells at the target site, where it is translated into the active protein. Naked mRNA suffers from quick pharmacokinetic clearance, poor cellular association and facile degradation, significantly reducing the cytosolic dose and its therapeutic activity.[11] Given these drawbacks, numerous nonviral delivery strategies such as liposomes[12,13] and cationic polymers[14−19] which protect, improve pharmacokinetics and aid cytosolic delivery of RNA, have been developed. Strategies exploiting polycations operate by condensing the nucleic acid through electrostatic complexation, forming 100−

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.